Ryan Lamont

Ryan Lamont serves as Associate Professor in the Department of Medical Genetics at the University of Calgary's Cumming School of Medicine, maintaining a dual affiliation with Alberta Health Services as evidenced by his institutional email address. His academic position bridges clinical practice and fundamental research in medical genetics, operating within Canada's integrated academic health system model.

Dr. Lamont's research program centers on deciphering the genetic architecture of congenital anomalies and intellectual disability through advanced genomic technologies. His work exemplifies translational medicine by rapidly converting laboratory discoveries into clinical diagnostic applications. Notably, his team identified the molecular basis of a novel multisystem syndrome involving neurological and muscular dysfunction, revealing critical insights into cellular trafficking mechanisms. His secondary research pillar focuses on refining genetic diagnostics for congenital adrenal hyperplasia, particularly 21-hydroxylase deficiency variants.

His research interests span:

• Rare genetic disorder pathogenesis
• Next-generation sequencing applications
• Genotype-phenotype correlations in pediatric syndromes
• Diagnostic test development for endocrine genetic conditions
• Translational pipelines from discovery to clinical implementation

Dr. Lamont operates within a collaborative ecosystem connecting clinicians, laboratory scientists, and diagnostic services. His work demonstrates how academic medical genetics research directly impacts patient diagnosis and family counseling, particularly for conditions previously lacking molecular explanations. While specific lab infrastructure details aren't provided, his research model emphasizes multidisciplinary teamwork across clinical and research domains to solve complex genetic diagnostic challenges.